Narrative review / 2024
A review compares contemporary bariatric metabolic surgery and novel incretin mimetic therapies for managing obesity.
This review evaluates the advantages and disadvantages of modern pharmacologic and surgical weight management strategies for obesity. It examines data on anticipated weight loss, glycemic control, cardiometabolic improvements, and possible adverse outcomes associated with incretin-based drugs and bariatric metabolic surgery. The authors note that while lifestyle changes provide health benefits, weight loss from lifestyle alone is modest and hard to sustain.
- Study type
- Narrative review
- Who was studied
- Patients with obesity
- What was measured
- Weight loss, glycemic control, cardiometabolic benefits, and adverse effects
THE PAPER
Contemporary Management of Obesity: A Comparison of Bariatric Metabolic Surgery and Novel Incretin Mimetic Drugs.
Singh A, Nissen SE. Diabetes Technol Ther, 2024.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.